CAS 195514-63-7

Bis[1-[2(S)-(3,4,5-Trimethoxypheny)butyryl]piperidine-2(S)-carboxylic acid] ester with 1,2-ethanediylbis[imino(2-oxo-2,1-ethanediyl)oxy-3,1-phenylene[(1R)-3-(3,4-dimethoxyphenyl)propylidene]] ester

Description:

The chemical substance known as Bis[1-[2(S)-(3,4,5-trimethoxyphenyl)butyryl]piperidine-2(S)-carboxylic acid] ester with 1,2-ethanediylbis[imino(2-oxo-2,1-ethanediyl)oxy-3,1-phenylene[(1R)-3-(3,4-dimethoxyphenyl)propylidene]] ester, identified by the CAS number 195514-63-7, is a complex organic compound characterized by its intricate molecular structure. This substance features multiple functional groups, including esters, amines, and aromatic rings, which contribute to its potential biological activity and chemical reactivity. The presence of trimethoxyphenyl and dimethoxyphenyl moieties suggests possible interactions with biological targets, making it of interest in medicinal chemistry. Its piperidine and butyric acid components may influence its pharmacokinetic properties, such as solubility and permeability. The compound's stereochemistry, indicated by the (S) configurations, may also play a crucial role in its biological efficacy and specificity. Overall, this compound exemplifies the complexity often found in drug design, where multiple functional groups and stereochemical considerations are essential for achieving desired therapeutic effects.

Formula: C₇₈H₉₈N₄O₂₀

Synonyms:

• Ap-1903
• Ap1903

AP1903

CAS: 195514-63-7

Formula: C₇₈H₉₈N₄O₂₀

Purity: 98%

Color and Shape: Solid

Molecular weight: 1411.6275

Ref: IN-DA00ABIL

Rimiducid

CAS: 195514-63-7

Rimiducid

Purity: ≥98%

Molecular weight: 1411.63g/mol

Ref: 54-BUP04707

Rimiducid

CAS: 195514-63-7

Rimiducid, a tacrolimus analogue, dimerizes FKBP domains to activate Caspase 9 and induce apoptosis; binds FKBP12 weakly.

Formula: C₇₈H₉₈N₄O₂₀

Purity: 99.54%

Color and Shape: Solid

Molecular weight: 1411.63

Ref: TM-T14298

AP 1903

CAS: 195514-63-7

AP 1903 is a synthetic small molecule, which acts as a dimerizer ligand. It is derived from the modification of the macrolide antibiotic rapamycin to remove its immunosuppressive effects, thus enabling targeted control of cellular processes. The mode of action involves binding to engineered receptors on the cell surface that contain drug-dependent domains. This binding triggers the dimerization of these receptors, leading to downstream signaling and subsequent cellular responses.

Formula: C₇₈H₉₈N₄O₂₀

Purity: Min. 95%

Color and Shape: Powder

Molecular weight: 1,411.65 g/mol

Ref: 3D-VHA51463